Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy

Alireza Aminsharifi; Thomas J. Polascik

doi:10.1016/j.eururo.2018.01.022

Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy

Alireza Aminsharifi
, Thomas J. Polascik

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	234-235
Number of pages	2
Journal	European Urology
Volume	74
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2018.01.022
State	Published - Aug 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Urology

Access to Document

10.1016/j.eururo.2018.01.022

Cite this

@article{3280306f9b854be68cf771bb007af955,

title = "Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy",

author = "Alireza Aminsharifi and Polascik, \{Thomas J.\}",

year = "2018",

month = aug,

doi = "10.1016/j.eururo.2018.01.022",

language = "English (US)",

volume = "74",

pages = "234--235",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Re

T2 - Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy

AU - Aminsharifi, Alireza

AU - Polascik, Thomas J.

PY - 2018/8

Y1 - 2018/8

UR - https://www.scopus.com/pages/publications/85049118201

UR - https://www.scopus.com/pages/publications/85049118201#tab=citedBy

U2 - 10.1016/j.eururo.2018.01.022

DO - 10.1016/j.eururo.2018.01.022

M3 - Comment/debate

C2 - 29428367

AN - SCOPUS:85049118201

SN - 0302-2838

VL - 74

SP - 234

EP - 235

JO - European Urology

JF - European Urology

IS - 2

ER -

Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this